Bioethics Blogs

Seeking the proper balance of regulation of cellular therapies

The journal Nature is editorializing against something called the REGROW Act, proposed by Senator Mark Kirk as S. 2689.  Looks like it has been referred to Senate committee and is early in the process. A quick read of the bill is that it would direct the HHS Secretary to establish (through the FDA) a process for conditional approval of certain cellular therapies—which would include certain… // Read More »

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.